Kariminejad- Najmabadi Pathology and Genetics Center, Tehran, Iran.
Neurology Division,Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran.
Arch Iran Med. 2014 Jul;17(7):471-4.
Intellectual Disabilities (ID), defined as a state of developmental deficit, result in significant limitation of intellect and poor adaptation behavior. A number of genetic factors can result in ID, such as chromosomal abnormalities, copy number variation, and single gene defect. Karyotyping is the routine method for detecting chromosomal abnormalities in patients with ID. More recently, the Multiplex Ligation-dependent Probe Amplification (MLPA) method has been applied for detecting microdeletion/duplication in patients with dysmorphism and ID.
A total of 100 patients with dysmorphism and ID have been referred to us since 2011. All patients were first evaluated clinically and a number of these individuals had normal karyotypes. We investigated duplications and deletions for 21 different microdeletion syndromes using MLPA kit (MRC-Holland).
We were able to identify aberrations in 12 (12%) patients clinically ascertained as follows: 5 Williams syndromes, 3 Miller- Dieker syndromes, 1 Sotos syndrome, 1 Angelman Syndrome, 1 Di-George syndrome and one patient with an abnormal 4p chromosomal region.
Our MLPA results indicate a high degree of concordance between the clinical data and the genotype. We suggest MLPA as the first screening method for children suffering from MR with normal karyotypes. In those cases where clinical findings were not compatible with the microdeletion syndrome identified by MLPA investigation, further studies such as FISH and aCGH were performed.
智力障碍(ID)定义为发育缺陷状态,导致智力严重受限和适应行为不良。许多遗传因素可导致 ID,如染色体异常、拷贝数变异和单基因缺陷。核型分析是检测 ID 患者染色体异常的常规方法。最近,多重连接依赖性探针扩增(MLPA)方法已应用于检测形态异常和 ID 患者的微缺失/重复。
自 2011 年以来,共有 100 名形态异常和 ID 的患者被转介给我们。所有患者均首先进行临床评估,其中一些患者核型正常。我们使用 MLPA 试剂盒(MRC-Holland)检测了 21 种不同的微缺失综合征的重复和缺失。
我们能够在 12 名(12%)经临床确定的患者中识别出异常:5 例威廉姆斯综合征、3 例米勒-迪克综合征、1 例 Sotos 综合征、1 例安格曼综合征、1 例迪乔治综合征和 1 例染色体 4p 区异常患者。
我们的 MLPA 结果表明临床数据与基因型之间具有高度一致性。我们建议 MLPA 作为核型正常的智力障碍儿童的首选筛查方法。在那些临床发现与 MLPA 调查确定的微缺失综合征不相符的情况下,进一步进行 FISH 和 aCGH 等研究。